Form D · Biotechnology
Born Science, LLC
Burleson, TX · CIK 0002143793
Offering snapshot reported Jul 29, 2026 · SEC filing
- Reported sold
- $250K Offering amount: $5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jun 11, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 29, 2026 | Initial | $250,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-592513
Simple Agreement for Future Equity (SAFE)
Source: Form D, filed Jul 29, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Edward Bell | Executive |
| Addison Mc Kenzie | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
505 Parkridge Blvd.
Burleson, TX, 76028
Phone: 972 978 4524
Burleson, TX, 76028
Phone: 972 978 4524